• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人血浆中6-[18F]氟-L-3,4-二羟基苯丙氨酸([18F]Fdopa)的药代动力学

Pharmacokinetics of plasma 6-[18F]fluoro-L-3,4-dihydroxyphenylalanine ([18F]Fdopa) in humans.

作者信息

Cumming P, Léger G C, Kuwabara H, Gjedde A

机构信息

Positron Imaging Laboratory, McConnell Brain Imaging Center, Montreal Neurological Institute, Canada.

出版信息

J Cereb Blood Flow Metab. 1993 Jul;13(4):668-75. doi: 10.1038/jcbfm.1993.85.

DOI:10.1038/jcbfm.1993.85
PMID:8314919
Abstract

Like native DOPA, [18F]-6-fluoro-L-3,4-dihydroxyphenylalanine ([18F]FDOPA) is subject to methylation and decarboxylation. To determine the rates of formation and elimination of [18F]FDOPA metabolites, plasma from human subjects undergoing positron emission tomographic (PET) studies was analyzed by high-performance liquid chromatography (HPLC). In addition to the principal metabolite O-methyl-[18F]FDOPA (OMe[18F]FDOPA), two decarboxylated metabolites were detected in plasma from carbidopa pretreated subjects. The concentrations of each metabolite during 90 min following tracer injection could be described as a function of the concentration of [18F]FDOPA, and two rate constants; k0, the rate of formation, and k-1, the rate of clearance. Plasma metabolite time series generated from total plasma activity curves and measured rate constants were in close agreement with the actual concentrations determined by HPLC fractionation. Population means for k0 (0.011 +/- 0.002 min-1) and k-1 (0.010 +/- 0.003 min-1) were used to generate "simulated" plasma curves. The measured and generated plasma curves were used as inputs for estimation of partition and decarboxylation coefficients of [18F]FDOPA in brain. The use of generated input functions from normal population means of transfer coefficients did not introduce a systematic error into the estimate of the enzyme activity. However, the high variability of these estimates in patients precludes the use of this technique as an alterative to individual HPLC measurements.

摘要

与天然多巴一样,[18F]-6-氟-L-3,4-二羟基苯丙氨酸([18F]FDOPA)会发生甲基化和脱羧反应。为了确定[18F]FDOPA代谢物的生成和消除速率,对接受正电子发射断层扫描(PET)研究的人类受试者的血浆进行了高效液相色谱(HPLC)分析。除了主要代谢物O-甲基-[18F]FDOPA(OMe[18F]FDOPA)外,在接受卡比多巴预处理的受试者的血浆中还检测到两种脱羧代谢物。示踪剂注射后90分钟内每种代谢物的浓度可以描述为[18F]FDOPA浓度和两个速率常数的函数;k0为生成速率,k-1为清除速率。由总血浆活性曲线生成的血浆代谢物时间序列和测得的速率常数与通过HPLC分级分离确定的实际浓度密切一致。k0(0.011±0.002 min-1)和k-1(0.010±0.003 min-1)的总体均值用于生成“模拟”血浆曲线。测得的和生成的血浆曲线被用作估算[18F]FDOPA在脑中的分配系数和脱羧系数的输入值。使用来自转移系数正常总体均值生成的输入函数并未在酶活性估算中引入系统误差。然而,这些估算值在患者中的高变异性使得该技术无法替代个体HPLC测量。

相似文献

1
Pharmacokinetics of plasma 6-[18F]fluoro-L-3,4-dihydroxyphenylalanine ([18F]Fdopa) in humans.人血浆中6-[18F]氟-L-3,4-二羟基苯丙氨酸([18F]Fdopa)的药代动力学
J Cereb Blood Flow Metab. 1993 Jul;13(4):668-75. doi: 10.1038/jcbfm.1993.85.
2
Kinetics and modeling of L-6-[18F]fluoro-dopa in human positron emission tomographic studies.
J Cereb Blood Flow Metab. 1991 Nov;11(6):898-913. doi: 10.1038/jcbfm.1991.155.
3
The effects of carbidopa administration on 6-[18F]fluoro-L-dopa kinetics in positron emission tomography.卡比多巴给药对正电子发射断层扫描中6-[18F]氟-L-多巴动力学的影响。
J Nucl Med. 1992 Aug;33(8):1472-7.
4
L-6-[18F]fluoro-dopa metabolism in monkeys and humans: biochemical parameters for the formulation of tracer kinetic models with positron emission tomography.L-6-[18F]氟多巴在猴子和人类中的代谢:用于正电子发射断层扫描示踪动力学模型构建的生化参数
J Cereb Blood Flow Metab. 1991 Nov;11(6):890-7. doi: 10.1038/jcbfm.1991.154.
5
Human striatal L-dopa decarboxylase activity estimated in vivo using 6-[18F]fluoro-dopa and positron emission tomography: error analysis and application to normal subjects.使用6-[18F]氟多巴和正电子发射断层扫描在体内估计人类纹状体L-多巴脱羧酶活性:误差分析及其在正常受试者中的应用。
J Cereb Blood Flow Metab. 1993 Jan;13(1):43-56. doi: 10.1038/jcbfm.1993.7.
6
Fluorodopa positron emission tomography with an inhibitor of catechol-O-methyltransferase: effect of the plasma 3-O-methyldopa fraction on data analysis.使用儿茶酚-O-甲基转移酶抑制剂的氟多巴正电子发射断层扫描:血浆3-O-甲基多巴分数对数据分析的影响。
J Cereb Blood Flow Metab. 1996 Sep;16(5):854-63. doi: 10.1097/00004647-199609000-00010.
7
Plasma L-[18F]6-fluorodopa input function: a simplified method.血浆L-[18F]6-氟多巴输入函数:一种简化方法。
J Cereb Blood Flow Metab. 1992 Sep;12(5):881-4. doi: 10.1038/jcbfm.1992.121.
8
Cerebral 6-[(18)F]fluoro-L-DOPA (FDOPA) metabolism in pig studied by positron emission tomography.用正电子发射断层扫描研究猪脑内6-[(18)F]氟-L-多巴(FDOPA)的代谢。
Synapse. 1999 Sep 15;33(4):247-58. doi: 10.1002/(SICI)1098-2396(19990915)33:4<247::AID-SYN1>3.0.CO;2-6.
9
PET studies of net blood-brain clearance of FDOPA to human brain: age-dependent decline of [18F]fluorodopamine storage capacity.FDOPA向人脑的净血脑清除率的正电子发射断层扫描(PET)研究:[18F]氟多巴胺储存能力的年龄依赖性下降。
J Cereb Blood Flow Metab. 2005 Jul;25(7):807-19. doi: 10.1038/sj.jcbfm.9600079.
10
Blood-brain transfer and metabolism of 6-[18F]fluoro-L-dopa in rat.大鼠体内6-[18F]氟-L-多巴的血脑转运与代谢
J Cereb Blood Flow Metab. 1990 Sep;10(5):707-19. doi: 10.1038/jcbfm.1990.124.

引用本文的文献

1
Kinetics of the amino acid uptake tracer O-(2-[F]fluoroethyl)-L-tyrosine (FET) in human brain.氨基酸摄取示踪剂O-(2-[F]氟乙基)-L-酪氨酸(FET)在人脑中的动力学
EJNMMI Res. 2025 Jul 22;15(1):90. doi: 10.1186/s13550-025-01279-7.
2
Single time point quantitation of cerebral glucose metabolism by FDG-PET without arterial sampling.无需动脉采样,通过氟代脱氧葡萄糖正电子发射断层扫描(FDG-PET)对脑葡萄糖代谢进行单次时间点定量分析。
EJNMMI Res. 2023 Nov 30;13(1):104. doi: 10.1186/s13550-023-01049-3.
3
The effect of AUT00206, a Kv3 potassium channel modulator, on dopamine synthesis capacity and the reliability of [F]-FDOPA imaging in schizophrenia.
AUT00206,一种钾离子通道调节剂,对精神分裂症患者多巴胺合成能力及 [F]-FDOPA 成像的可靠性的影响。
J Psychopharmacol. 2022 Sep;36(9):1061-1069. doi: 10.1177/02698811221122031.
4
Striatal dopaminergic alterations in individuals with copy number variants at the 22q11.2 genetic locus and their implications for psychosis risk: a [18F]-DOPA PET study.22q11.2 遗传位点拷贝数变异个体纹状体多巴胺能改变及其对精神病风险的影响:[18F]-DOPA PET 研究。
Mol Psychiatry. 2023 May;28(5):1995-2006. doi: 10.1038/s41380-021-01108-y. Epub 2021 May 12.
5
Preclinical Evaluation of [F]FACH in Healthy Mice and Piglets: An F-Labeled Ligand for Imaging of Monocarboxylate Transporters with PET.[F]FACH 在健康小鼠和仔猪中的临床前评估:用于 PET 成像单羧酸转运蛋白的 F 标记配体。
Int J Mol Sci. 2021 Feb 6;22(4):1645. doi: 10.3390/ijms22041645.
6
A potential biomarker for treatment stratification in psychosis: evaluation of an [F] FDOPA PET imaging approach.精神分裂症治疗分层的潜在生物标志物:[F] FDOPA PET 成像方法的评估。
Neuropsychopharmacology. 2021 May;46(6):1122-1132. doi: 10.1038/s41386-020-00866-7. Epub 2020 Sep 22.
7
Dopamine and Glutamate in Antipsychotic-Responsive Compared With Antipsychotic-Nonresponsive Psychosis: A Multicenter Positron Emission Tomography and Magnetic Resonance Spectroscopy Study (STRATA).抗精神病药物反应性与非反应性精神病的多巴胺和谷氨酸:一项多中心正电子发射断层扫描和磁共振波谱研究(STRATA)。
Schizophr Bull. 2021 Mar 16;47(2):505-516. doi: 10.1093/schbul/sbaa128.
8
The relationship between grey matter volume and striatal dopamine function in psychosis: a multimodal F-DOPA PET and voxel-based morphometry study.精神分裂症患者灰质体积与纹状体多巴胺功能的关系:一项多模态 F-DOPA PET 和基于体素的形态测量学研究。
Mol Psychiatry. 2021 Apr;26(4):1332-1345. doi: 10.1038/s41380-019-0570-6. Epub 2019 Nov 5.
9
The effect of a genetic variant at the schizophrenia associated AS3MT/BORCS7 locus on striatal dopamine function: A PET imaging study.精神分裂症相关 AS3MT/BORCS7 基因座上遗传变异对纹状体多巴胺功能的影响:一项 PET 成像研究。
Psychiatry Res Neuroimaging. 2019 Sep 30;291:34-41. doi: 10.1016/j.pscychresns.2019.07.005. Epub 2019 Jul 19.
10
The Effects of Antipsychotic Treatment on Presynaptic Dopamine Synthesis Capacity in First-Episode Psychosis: A Positron Emission Tomography Study.抗精神病药物治疗对首发精神病患者突触前多巴胺合成能力的影响:一项正电子发射断层扫描研究。
Biol Psychiatry. 2019 Jan 1;85(1):79-87. doi: 10.1016/j.biopsych.2018.07.003. Epub 2018 Jul 11.